News Focus
News Focus
icon url

DewDiligence

09/21/11 2:15 PM

#127012 RE: oldberkeley #127011

You’re not missing anything, but I would substitute the word improbable for impossible. It isn’t necessary for MNTA to claim impossibility for the lawsuit to be taken seriously by the Court.
icon url

biomaven0

09/21/11 2:38 PM

#127015 RE: oldberkeley #127011

it's impossible for TEVA (insert Amphastar if applicable) or any company to manufacture enoxaparin without violating certain of MNTA's patents during the process



Sanofi manufactures enox without violating any of MNTA's patents, so clearly it is possible to do so.

I'm guessing the delayed launch is simply because they got taken by surprise by the FDA action so they need to build stocks.

Peter